Safety and preliminary efficacy of human adult liver progenitor cells (HepaStem™) in patients with acute-on-chronic liver failure (ACLF) or acute decompensation (AD) at risk of developing ACLF

HepaStem (heterologous human adult liver-derived mesenchymal stem cells) - Promethera Biosciences

https://bwge2020.sched.com/event/YorC/safety-and-preliminary-efficacy-of-human-adult-liver-progenitor-cells-hepastem-in-patients-with-acute-on-chronic-liver-failure-aclf-or-acute-decompensation-ad-at-risk-of-developing-aclf

F. NEVENS 1; T. GUSTOT 2; P. LATERRE 3; L. LASSER 4; L. HARALAMPIEV 5; V. VARGAS 6; D. LYUBOMIROVA 7; A. ALBILLOS 8; V. BARTHEL 9; N. CLERGET-CHOSSAT 9; E. SOKAL 9

Feb 24, 2020